benefits of glp 1 agonists Frontiers Do The Benefits of GLP-1

Among patients with UC, those treated with GLP1RA had lower rates of corticosteroid use (39.9% vs 76.0%), emergency department visits (41.9% vs 52.7%), hospitalization (30.6% vs 55.8%), intestinal resection (17.8% vs 53.9%), and mortality (5.8% vs 10.9%)

GLP-1 access Disparities in access to GLP-1s have been documented by race/ethnicity and socioeconomic status [228]

Research into the area is far from complete

As compared to loop diuretics, SGLT2-i may distinctly regulate the interstitial versus intravascular compartment selectively reducing interstitial oedema, which has been observed in HF and DKD, with minimal change in blood volume